iBio
IBIO
#10064
Rank
โ‚ฌ66.35 M
Marketcap
1,03ย โ‚ฌ
Share price
-1.68%
Change (1 day)
44.10%
Change (1 year)

Market capitalization of iBio (IBIO)

Market cap: โ‚ฌ66.35 Million

As of September 2026 iBio has a market cap of โ‚ฌ66.35 Million. This makes iBio the world's 10064th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of iBio from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ66.35 M83.4%
2025โ‚ฌ36.17 M67.95%
2024โ‚ฌ21.54 M766.91%
2023โ‚ฌ2.48 M-33.38%
2022โ‚ฌ3.72 M-96.47%
2021โ‚ฌ0.10 B-41.55%
2020โ‚ฌ0.18 B1390.47%
2019โ‚ฌ12.12 M-2.23%
2018โ‚ฌ12.4 M-27.12%
2017โ‚ฌ17.02 M-49.13%
2016โ‚ฌ33.46 M-15.5%
2015โ‚ฌ39.6 M-2.31%
2014โ‚ฌ40.54 M159.35%
2013โ‚ฌ15.63 M-30.18%
2012โ‚ฌ22.38 M8.18%
2011โ‚ฌ20.69 M-73.02%
2010โ‚ฌ76.71 M331.96%
2009โ‚ฌ17.76 M908.06%
2008โ‚ฌ1.76 M

End of Day market cap according to different sources

On Sep 28th, 2026 the market cap of iBio was reported to be:

โ‚ฌ66.35 Million
by Nasdaq info icon info icon
โ‚ฌ66.35 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ577.97 B 870,947.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
โ‚ฌ0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚ฌ1.81 B 2,640.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.31 B 367.49%๐Ÿ‡บ๐Ÿ‡ธ USA